(Total Views: 173)
Posted On: 10/20/2021 11:50:47 AM
Post# of 8463
$GTCH's wearable version is planned to include the same features as the finger-touch device including intelligent health monitoring and alert capabilities
SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT” or the “Company”) has on its roadmap, a wearable version of the qTerm device. The finger-touch version prototype of the device is now under manufacturing; and the company plans to start a wearable version next year. GBT's qTerm, a human vitals device, is aimed to measure human vitals with the touch of a finger.
According to Gartner’s (Gartner Forecasts Global Spending on Wearable Devices to Total $81.5 Billion in 2021) forecast, the world will spend about $81.5 billion on wearable devices in 2021, a significant rise compared to 2020. This rise is directly correlated with the global pandemic and the importance of health monitoring in our lives.
SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT” or the “Company”) has on its roadmap, a wearable version of the qTerm device. The finger-touch version prototype of the device is now under manufacturing; and the company plans to start a wearable version next year. GBT's qTerm, a human vitals device, is aimed to measure human vitals with the touch of a finger.
According to Gartner’s (Gartner Forecasts Global Spending on Wearable Devices to Total $81.5 Billion in 2021) forecast, the world will spend about $81.5 billion on wearable devices in 2021, a significant rise compared to 2020. This rise is directly correlated with the global pandemic and the importance of health monitoring in our lives.
(0)
(0)
